Heart Valve Voice US has joined with other patient groups and physician organizations to form the Heart Valve Disease Policy Task Force, to make sure the patient voice is heard as the Centers for Medicare & Medicaid Services (CMS) prepares to make a decision that could affect access to Transcatheter Aortic Valve Replacement (TAVR). TAVR is a minimally-invasive alternative to open heart surgery for many people. With TAVR, an interventional cardiologist deploys a new valve into the patient’s heart via an artery.
About a dozen HVV patients travelled to Washington, D.C., in late September, and urged their members of Congress to contact CMS. We also conducted a briefing for congressional staff members and the media. You can view the briefing, called “Don’t Miss a Beat: The Latest on Heart Valve Disease Research & Policy” on Facebook here.
For additional information, take a look at an August 17 National Public Radio/Kaiser Health News article by Phil Galewitz.
In June, CMS decided to reconsider its 2012 National Coverage Determination, indicating under what circumstances Medicare pays for TAVR.